FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/13/2012 |
3. Issuer Name and Ticker or Trading Symbol
IGATE CORP [ IGTE ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 2,500(1) | D | |
Common Stock | 22,000(2) | D | |
Common Stock | 88,000(3) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (Right to Buy) | (4) | 03/01/2020 | Common Stock | 55,000 | $9.07 | D |
Explanation of Responses: |
1. Represents restricted stock, all of which will vest on March 1, 2014. |
2. Represents restricted stock, of which 5,500 shares will vest on May 12, 2014, 5,500 shares will vest on May 12, 2015 and 11,000 shares will vest on May 12, 2016. |
3. Represents the target number of performance shares to be received upon attainment of the Company's twelve-month trailing adjusted EBITDA goal at any fiscal quarter end within the five and a half year period of January 1, 2011 through June 30, 2016 (the "Performance Period"). In the event the Company achieves its maximum twelve-month trailing adjusted EBITDA goal at any fiscal quarter end within the Performance Period, two times the target number of shares will vest. |
4. The options vest as follows: 13,750 shares each vested on March 1, 2011 and March 1, 2012, and 13,750 shares each will vest on March 1, 2013 and March 1, 2014. |
Remarks: |
EVP and Co-Head of Consulting & Solutions Exhibit List Exhibit 24 - Power of Attorney |
/s/ Teresa V. Pahl, Attorney-in-Fact | 04/23/2012 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |